Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Inactive
Last updated: May 30, 2025
Subtilosin
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal Gel
  • Intended Duration: Pericoital
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Rutgers, University of Alberta, Universidad de Buenos Aires
Inactive
Last updated: May 29, 2025
ORAL T-8

Oral Testosterone Male Contraceptive

  • User: Male
  • Hormonal: Hormonal
  • Delivery Type: Oral
  • Intended Duration: Undetermined
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): University of Washington, GlaxoSmithKline, NICHD
Inactive
Last updated: May 29, 2025
NOMAC Vaginal Ring
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Dinox, Merck
Inactive
Last updated: May 29, 2025
Nestorone®/Estradiol Transdermal Gel

Nestragel

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Transdermal
  • Intended Duration: Short-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Population Council, Antares Pharma
Inactive
Last updated: May 29, 2025
Injectable PLGA Microspheres with GES + EE
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Injectable
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Peking University
Inactive
Last updated: May 29, 2025
Single-Rod Gestodene Implant
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Subdermal
  • Intended Duration: Long-Acting
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): Shanghai Institute of Planned Parenthood Research
Inactive
Last updated: May 29, 2025
Nonwoven Vaginal MPT
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal - Other
  • Intended Duration: Pericoital
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): FHI 360, RTI International, University of the Witwatersrand
Inactive
Last updated: May 29, 2025
Desogestrel + Testosterone Oral Contraceptive
  • User: Male
  • Hormonal: Hormonal
  • Delivery Type: Oral
  • Intended Duration: Undetermined
  • Development Stage: Phase I
  • Developer(s)/Researcher(s): University of Edinburgh, University of Washington
Inactive
Last updated: May 29, 2025
BioRing MPT IVR

Cornell Vaginal Ring

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Undetermined
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): BioRings, Weill Cornell Medicine
Inactive
Last updated: May 29, 2025
Cinchonine Derivatives

3-(1-alkyl/aminoalkyl-3-vinyl-piperidin-4-yl)-1-(quinolin-4-yl)-propan-1-one, Quinine

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal Gel
  • Intended Duration: Pericoital
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Central Drug Research Institute, Lucknow; University of Lagos